Q2 EPS Estimates for Core Laboratories Cut by Zacks Research

Core Laboratories Inc. (NYSE:CLB) – Equities researchers at Zacks Research dropped their Q2 2025 earnings per share (EPS) estimates for shares of Core Laboratories in a research report issued to clients and investors on Wednesday, March 26th. Zacks Research analyst T. Saha now expects that the oil and gas company will earn $0.21 per share for the quarter, down from their prior forecast of $0.25. The consensus estimate for Core Laboratories’ current full-year earnings is $0.96 per share. Zacks Research also issued estimates for Core Laboratories’ Q1 2026 earnings at $0.18 EPS, Q4 2026 earnings at $0.34 EPS and FY2027 earnings at $1.28 EPS.

Separately, Citigroup upgraded Core Laboratories from a “sell” rating to a “neutral” rating and upped their target price for the stock from $15.00 to $16.00 in a report on Wednesday, March 12th. One investment analyst has rated the stock with a sell rating and four have given a hold rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $17.50.

Core Laboratories Price Performance

Shares of NYSE CLB opened at $15.30 on Friday. The company has a debt-to-equity ratio of 0.49, a current ratio of 2.32 and a quick ratio of 1.71. Core Laboratories has a 1 year low of $12.95 and a 1 year high of $25.13. The company’s 50-day moving average is $16.44 and its 200 day moving average is $18.09. The stock has a market capitalization of $716.45 million, a P/E ratio of 23.18, a P/E/G ratio of 0.99 and a beta of 2.38.

Core Laboratories (NYSE:CLB) last announced its earnings results on Wednesday, January 29th. The oil and gas company reported $0.23 EPS for the quarter, meeting analysts’ consensus estimates of $0.23. Core Laboratories had a return on equity of 16.24% and a net margin of 5.99%.

Hedge Funds Weigh In On Core Laboratories

Several institutional investors and hedge funds have recently modified their holdings of the stock. State Street Corp raised its holdings in Core Laboratories by 2.9% in the 3rd quarter. State Street Corp now owns 1,975,016 shares of the oil and gas company’s stock worth $36,597,000 after acquiring an additional 56,187 shares during the last quarter. Geode Capital Management LLC raised its stake in shares of Core Laboratories by 0.7% in the third quarter. Geode Capital Management LLC now owns 1,053,204 shares of the oil and gas company’s stock worth $19,521,000 after purchasing an additional 7,721 shares during the last quarter. Boston Trust Walden Corp lifted its holdings in shares of Core Laboratories by 2.7% during the fourth quarter. Boston Trust Walden Corp now owns 617,336 shares of the oil and gas company’s stock valued at $10,686,000 after purchasing an additional 16,503 shares in the last quarter. Barclays PLC boosted its position in shares of Core Laboratories by 288.2% during the third quarter. Barclays PLC now owns 83,570 shares of the oil and gas company’s stock valued at $1,549,000 after buying an additional 62,042 shares during the last quarter. Finally, Amundi increased its holdings in Core Laboratories by 194.8% in the 4th quarter. Amundi now owns 32,968 shares of the oil and gas company’s stock worth $600,000 after buying an additional 21,783 shares in the last quarter. 97.81% of the stock is currently owned by institutional investors.

Core Laboratories Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Monday, March 3rd. Shareholders of record on Monday, February 10th were issued a $0.01 dividend. This represents a $0.04 annualized dividend and a yield of 0.26%. The ex-dividend date was Monday, February 10th. Core Laboratories’s dividend payout ratio (DPR) is 6.06%.

Core Laboratories Company Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.